Cargando…

Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples

The BioFire® COVID-19 Test and Respiratory Panel 2.1 (RP2.1) are rapid, fully automated assays for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal swabs. In the case of the RP2.1, an additional 21 viral and bacterial pathogens can be detected. Both tes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckbo, Eric J., Locher, Kerstin, Caza, Melissa, Li, Lisa, Lavergne, Valery, Charles, Marthe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654322/ https://www.ncbi.nlm.nih.gov/pubmed/33340934 http://dx.doi.org/10.1016/j.diagmicrobio.2020.115260

Ejemplares similares

Multicenter Evaluation of the BioFire Respiratory Panel 2.1 (RP2.1) for Detection of SARS-CoV-2 in Nasopharyngeal Swab Samples
por: Berry, Gregory J., et al.
Publicado: (2022)

Multicenter Evaluation of BioFire FilmArray Respiratory Panel 2 for Detection of Viruses and Bacteria in Nasopharyngeal Swab Samples
por: Leber, Amy L., et al.
Publicado: (2018)

Evaluation of BioFire Respiratory Panel 2 plus for Detection of Bordetella pertussis in Nasopharyngeal Swab Specimens from Children with Clinically Suspected Pertussis
por: Li, Chi, et al.
Publicado: (2023)

1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility
por: Strength, Rachel, et al.
Publicado: (2021)

Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2
por: Creager, Hannah M., et al.
Publicado: (2020)

BioFire FilmArray respiratory panel RP2.1 for SARS-CoV-2 detection: The pitfalls
por: Chang, Yu-Chang, et al.
Publicado: (2022)

Clinical Evaluation of BioFire COVID-19 Test, BioFire Respiratory Panel 2.1, and Cepheid Xpert Xpress SARS-CoV-2 Assays for Sample-to-Answer Detection of SARS-CoV-2
por: Park, Joonhong, et al.
Publicado: (2023)

Performance of the BioFire Blood Culture Identification 2 panel for the diagnosis of bloodstream infections
por: Peri, Anna Maria, et al.
Publicado: (2022)

Approach to Assessment of New Swabs and Viral Transport Media for SARS-CoV-2 Testing
por: Locher, Kerstin, et al.
Publicado: (2021)

Evaluation of the BioFire Gastrointestinal Panel to Detect Diarrheal Pathogens in Pediatric Patients
por: Jo, Sung Jin, et al.
Publicado: (2021)

Respiratory coinfections in COVID-19 patients evaluated by BioFire Pneumonia Panel
por: Assal, Hebatallah Hany, et al.
Publicado: (2021)

2072. Clinical Evaluation of the BioFire® Global Fever Special Pathogens Panel
por: Collins, Brittany, et al.
Publicado: (2023)

BioFire FilmArray Decreases Infection Control Isolation Times by 4 days in ICU, BMT and Respiratory Wards
por: Wong, Titus, et al.
Publicado: (2017)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

300. Pediatric Center Evaluation of the BioFire(®) Blood Culture Identification 2 Panel Versus the Original BioFire(®)FilmArray(®) Blood Culture Identification Panel for the Detection of Microorganisms and Resistance Markers in Positive Blood Cultures
por: Pierce, Kristina B, et al.
Publicado: (2020)

Impact of the BioFire FilmArray gastrointestinal panel on patient care and infection control
por: Machiels, Julian D., et al.
Publicado: (2020)

2002. BioFire® Filmarray® Pneumonia Panel: A Powerful Rapid Diagnostic Test for Antimicrobial Stewardship
por: Furukawa, Daisuke, et al.
Publicado: (2019)

Low Detection Rate of Bordetella pertussis Using the BioFire FilmArray Respiratory Panel 2plus
por: Guillot, Sophie, et al.
Publicado: (2020)

Clinical Impact of the Expanded BioFire Blood Culture Identification 2 Panel in a U.S. Children’s Hospital
por: Graff, Kelly E., et al.
Publicado: (2021)

Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels
por: Sze, Dorothy T. T., et al.
Publicado: (2021)

2002. Evaluation of the BioFire(®) Pneumonia Panel in ICU Patients With Suspected Ventilator-Associated Pneumonia
por: Iannello, Alexandra, et al.
Publicado: (2018)

Enhanced Detection of Community-Acquired Pneumonia Pathogens With the BioFire® Pneumonia FilmArray® Panel
por: Gilbert, David N., et al.
Publicado: (2021)

Automated 16S Sequencing Using an R-Based Analysis Module for Bacterial Identification
por: Locher, Kerstin, et al.
Publicado: (2022)

701. Rapid Detection of Antimicrobial Resistance Determinants with the BioFire(®) System
por: Marxreiter, Stefanie, et al.
Publicado: (2018)

Comparative Evaluation of Allplex Respiratory Panels 1, 2, 3, and BioFire FilmArray Respiratory Panel for the Detection of Respiratory Infections
por: Lade, Harshad, et al.
Publicado: (2021)

535. Evaluation of the BioFire Blood Culture Identification (BCID2) panel for transplant recipients with a bloodstream infection
por: Palacios, Carlo Foppiano, et al.
Publicado: (2022)

Contribution of the BioFire(®) FilmArray(®) Meningitis/Encephalitis Panel: Assessing Antimicrobial Duration and Length of Stay
por: Dack, Kyle, et al.
Publicado: (2019)

2148. Performance of the BioFire FilmArray Gastrointestinal Panel in a Clinical Setting of Infectious Diarrhea
por: Aguirre-García, Gloria Mayela, et al.
Publicado: (2019)

123. Utilization of the BioFire® FilmArray® Pneumonia Panel in Critically Ill Patients with Influenza Pneumonia
por: Ereshefsky, Benjamin, et al.
Publicado: (2020)

Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing
por: Ginocchio, Christine C., et al.
Publicado: (2021)

A four specimen-pooling scheme reliably detects SARS-CoV-2 and influenza viruses using the BioFire FilmArray Respiratory Panel 2.1
por: Ranadheera, Charlene, et al.
Publicado: (2022)

The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration
por: Quicke, Kendra M., et al.
Publicado: (2022)

1108. Diagnostic Yield of the BioFire FilmArray Gastrointestinal Panel in Hospitalized Children at an Academic Children’s Center
por: Madigan, Theresa, et al.
Publicado: (2018)

1793. Clinical Outcomes among Febrile Infants Before and After Implementation of BioFire® FilmArray® Panels
por: Crook, Jennifer, et al.
Publicado: (2019)

106. Impact and Evaluation of BioFire® FilmArray® Respiratory Panel on Clinical Decision Making and Antibiotic Prescribing
por: Manatrey-Lancaster, Jenna J, et al.
Publicado: (2020)

Impact of BioFire FilmArray respiratory panel results on antibiotic days of therapy in different clinical settings
por: Manatrey-Lancaster, Jenna J., et al.
Publicado: (2021)

913. Impact of BioFire(®) FilmArray(®) Blood Culture Identification Panels on Time to Optimal Antimicrobial Therapy
por: Vyas, Shivam, et al.
Publicado: (2022)

164. BioFire FilmArray Pneumonia Panel Implementation: Examining Appropriate Usage and Opportunities for Diagnostic Stewardship
por: Zelus, Casey S, et al.
Publicado: (2022)

Evaluation of the BioFire(®) FilmArray(®) Pneumonia Panel with Conventional Bacterial Culture in Conjunction with Leukocyte Esterase Test
por: Yoo, In Young, et al.
Publicado: (2023)

Diagnostic accuracy of the BioFire® FilmArray® pneumonia panel in COVID-19 patients with ventilator-associated pneumonia
por: Cojuc-Konigsberg, Gabriel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sek6e40fcqc8at080gj2pnfn8l